Astec LifeSciences Limited, a subsidiary of Godrej Agrovet Limited (GAVL), will showcase CDMO capabilities at Chemspec Europe 2025, taking place on June 4–5 at Koelnmesse, Germany.

The 38th Edition of the event will host over 400 key suppliers from 22 countries, providing a global platform for innovation and collaboration. Through its participation, Astec aims to connect with leading players in agrochemicals, specialty chemicals, and pharmaceuticals sectors while showcasing its enhanced capabilities in custom synthesis, scale-up, process optimization, and commercial manufacturing.

Talking to Indian Chemical News, Burjis Godrej, MD & CEO, Astec LifeSciences Limited said, “Astec LifeSciences is undergoing a significant transformation, transitioning from a legacy enterprise-focused model to a trusted global CDMO partner. Chemspec Europe offers the perfect platform to highlight this evolution and engage with innovators on a global scale.”

“With substantial investments in state-of-the-art R&D infrastructure and world-class manufacturing over the past two years, we are eager to collaborate with global innovators—not just as a vendor but as a strategic long-term partner,” added Godrej.

In 2023, Astec inaugurated an advanced R&D center in Rabale, Maharashtra. Built with an investment of US $1.4 million, the facility is dedicated to driving innovation, developing sustainable solutions, and offering specialized CDMO services to innovator companies worldwide.

Astec’s presence at Chemspec Europe reflects the Godrej Industries Group’s commitment to elevating the company into a world-class CDMO player, underscoring its long-term vision and dedication to delivering excellence in sustainable and compliant manufacturing solutions.